Sentynl
1 known investors
Find your way into Sentynl
53 people in our graph share verified history with the Sentynl team — schools, employers, funds. One of them is your warm intro.
Chris Murphyunlockedknows Matt Heck · together at Darla Moore School of Business at the University of South Carolina (overlapped)
×11knows the team · via Darla Moore School of Business at the University of South Carolina
A biopharmaceutical company developing novel medicines for rare diseases, serving patients and caregivers from early detection through therapeutic intervention.
Founders & leadership
MH

Matt HeckFounder & CEOHe previously co-founded Victory Pharmaceuticals where he served as CEO, was VP of Sales at DJ Pharma (which was acquired by Biovail), and held commercial roles at Dura Pharmaceuticals and Dial Corporation; he holds a Bachelor of Arts in marketing from the University of South Carolina.
Investors · 1
Frequently asked questions
- What does Sentynl do?
- A biopharmaceutical company developing novel medicines for rare diseases, serving patients and caregivers from early detection through therapeutic intervention.
- Who founded Sentynl?
- Sentynl was founded by Matt Heck.
- Who are Sentynl's investors?
- Sentynl's investors include Avego BioScience Capital.

